Discovering 3 UK Penny Stocks With Market Caps As Low As £9M

In This Article:

The UK market has recently faced challenges, with the FTSE 100 closing lower due to weak trade data from China, highlighting global economic interdependencies. Despite such fluctuations in major indices, there remains a niche for investors seeking opportunities beyond blue-chip stocks. Penny stocks, though often associated with smaller or newer companies, can offer significant potential when backed by strong financials and fundamentals.

Top 10 Penny Stocks In The United Kingdom

Name

Share Price

Market Cap

Financial Health Rating

ME Group International (LSE:MEGP)

£2.20

£828.88M

★★★★★★

Next 15 Group (AIM:NFG)

£3.76

£373.95M

★★★★☆☆

Supreme (AIM:SUP)

£1.575

£183.66M

★★★★★★

FRP Advisory Group (AIM:FRP)

£1.44

£355.43M

★★★★★★

Serabi Gold (AIM:SRB)

£0.81

£61.34M

★★★★★★

Ultimate Products (LSE:ULTP)

£1.21

£103.3M

★★★★★★

Luceco (LSE:LUCE)

£1.33

£205.12M

★★★★★☆

Impax Asset Management Group (AIM:IPX)

£3.405

£435.71M

★★★★★★

Integrated Diagnostics Holdings (LSE:IDHC)

$0.372

$216.25M

★★★★★★

Stelrad Group (LSE:SRAD)

£1.475

£187.85M

★★★★★☆

Click here to see the full list of 465 stocks from our UK Penny Stocks screener.

Let's review some notable picks from our screened stocks.

MYCELX Technologies

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MYCELX Technologies Corporation is a clean water technology company that offers water treatment solutions to various sectors including oil and gas, power, marine, and heavy manufacturing across the Middle East, the United States, Australia, and internationally; it has a market cap of £9.15 million.

Operations: The company's revenue is generated from its Pollution and Treatment Control Products segment, which amounts to $8.84 million.

Market Cap: £9.15M

MYCELX Technologies Corporation, with a market cap of £9.15 million, operates in the clean water technology sector and has recently secured a CAD 1.5 million project in the Middle East for its REGEN installation, boosting its 2025 revenue forecast. Despite being unprofitable with declining earnings over the past five years, MYCELX is debt-free and has sufficient short-term assets to cover liabilities. The company reported half-year sales of US$3.5 million but faced a net loss of US$1.36 million compared to last year’s figures. Recent equity offerings indicate shareholder dilution but also provide additional capital for operations.

AIM:MYX Financial Position Analysis as at Nov 2024
AIM:MYX Financial Position Analysis as at Nov 2024

Tandem Group

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Tandem Group plc is involved in the design, development, distribution, and retail of sports, leisure, and mobility products in the United Kingdom with a market cap of £9.17 million.